
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 27, 2023, titled "Press Release on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023.".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 27, 2023, titled "Press Release on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023.".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma